Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Canadian Family Physician Medecin De Famille Canadien|February 16, 2020
Relationship between GP visits and time spent in-hospital among insulin-dependent Canadians with type 2 diabetesMaeve E Wickham, Corinne M HohlBMC Health Services Research|March 29, 2020
Emergency department-based medication review on outpatient health services utilization: interrupted time seriesSophie A Kitchen, Kimberlyn McGrail, Maeve E Wickham, et al.British Journal of Clinical Pharmacology|April 11, 2024
Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug eventsMaeve E Wickham, Kimberlyn M McGrail, Michael R Law, et al.Pediatrics|December 24, 2014
Maternal depressive symptoms during childhood and risky adolescent health behaviorsMaeve E Wickham, Ambikaipakan Senthilselvan, T Cameron Wild, et al.British Journal of Clinical Pharmacology|February 6, 2024
Validating methods used to identify non-adherence adverse drug events in Canadian administrative health dataMaeve E Wickham, Kimberlyn M McGrail, Michael R Law, et al.Pharmacoepidemiology and Drug Safety|September 20, 2024
Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort StudyMaeve E Wickham, Kimberlyn M McGrail, Michael R Law, et al.Journal of Medical Internet Research|December 10, 2021
The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods StudyErina Chan, Serena S Small, Maeve E Wickham, et al.CMAJ Open|July 20, 2019
Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia, CanadaCorinne M Hohl, Stephanie A Woo, Amber Cragg, et al.Plos One|February 14, 2017
Impact of early in-hospital medication review by clinical pharmacists on health services utilizationCorinne M Hohl, Nilu Partovi, Isabella Ghement, et al.British Journal of Clinical Pharmacology|October 22, 2019
Preventable adverse drug events: Descriptive epidemiologyStephanie A Woo, Amber Cragg, Maeve E Wickham, et al.Pageof 2